339 related articles for article (PubMed ID: 31805828)
1. Organoids: Past Learning and Future Directions.
O'Connell L; Winter DC
Stem Cells Dev; 2020 Mar; 29(5):281-289. PubMed ID: 31805828
[TBL] [Abstract][Full Text] [Related]
2. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
[TBL] [Abstract][Full Text] [Related]
3. A brief history of organoids.
Corrò C; Novellasdemunt L; Li VSW
Am J Physiol Cell Physiol; 2020 Jul; 319(1):C151-C165. PubMed ID: 32459504
[TBL] [Abstract][Full Text] [Related]
4. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
[TBL] [Abstract][Full Text] [Related]
5. Initiation, Expansion, and Cryopreservation of Human Primary Tissue-Derived Normal and Diseased Organoids in Embedded Three-Dimensional Culture.
Clinton J; McWilliams-Koeppen P
Curr Protoc Cell Biol; 2019 Mar; 82(1):e66. PubMed ID: 30265443
[TBL] [Abstract][Full Text] [Related]
6. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678
[TBL] [Abstract][Full Text] [Related]
7. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in organoid development and applications in disease modeling.
Rauth S; Karmakar S; Batra SK; Ponnusamy MP
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188527. PubMed ID: 33640383
[TBL] [Abstract][Full Text] [Related]
9. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
Elife; 2020 Nov; 9():. PubMed ID: 33138918
[TBL] [Abstract][Full Text] [Related]
10. Human airway organoid engineering as a step toward lung regeneration and disease modeling.
Tan Q; Choi KM; Sicard D; Tschumperlin DJ
Biomaterials; 2017 Jan; 113():118-132. PubMed ID: 27815996
[TBL] [Abstract][Full Text] [Related]
11. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
[TBL] [Abstract][Full Text] [Related]
13. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments.
Astashkina A; Grainger DW
Adv Drug Deliv Rev; 2014 Apr; 69-70():1-18. PubMed ID: 24613390
[TBL] [Abstract][Full Text] [Related]
14. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
[TBL] [Abstract][Full Text] [Related]
15. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
[TBL] [Abstract][Full Text] [Related]
16. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.
Brandenberg N; Hoehnel S; Kuttler F; Homicsko K; Ceroni C; Ringel T; Gjorevski N; Schwank G; Coukos G; Turcatti G; Lutolf MP
Nat Biomed Eng; 2020 Sep; 4(9):863-874. PubMed ID: 32514094
[TBL] [Abstract][Full Text] [Related]
17. Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine.
Hirokawa Y; Clarke J; Palmieri M; Tan T; Mouradov D; Li S; Lin C; Li F; Luo H; Wu K; Faux M; Tan CW; Lee M; Gard G; Gibbs P; Burgess AW; Sieber OM
Commun Biol; 2021 Sep; 4(1):1067. PubMed ID: 34518628
[TBL] [Abstract][Full Text] [Related]
18. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW
Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663
[TBL] [Abstract][Full Text] [Related]
19. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
20. Investigating Aspects of Renal Physiology and Pharmacology in Organ and Organoid Culture.
Lawrence ML; Elhendawi M; Davies JA
Methods Mol Biol; 2019; 1926():127-142. PubMed ID: 30742268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
